Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 2/20 | 0.49 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.49 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.49 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.49 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.49 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.49 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.45 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.40 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.39 |
| ▸ | GNRHR | P30968 | 1/20 | 0.38 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.38 |
| ▸ | DAO | P14920 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6202118 | 0.88 | MEN1 (0.43) | POLBMEN1PGRKMT2APTGS2 | |
| SCHEMBL15200742 | 0.88 | KMT2A (0.43) | POLBMEN1PGRKMT2APTGS2 | |
| SCHEMBL18751640 | 0.85 | TP53 (0.51) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL7560668 | 0.85 | POLB (0.45) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL7818937 | 0.83 | PTGS2 (0.44) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL12009980 | 0.81 | GRIN2D (0.43) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL852747 | 0.81 | KMT2A (0.55) | POLBMEN1PGRKMT2A | |
| SCHEMBL3466280 | 0.79 | POLB (0.41) | POLBGPBAR1MEN1PGRKMT2A | |
| SCHEMBL7563981 | 0.78 | GPBAR1 (0.40) | POLBGPBAR1MEN1PGRKMT2A | |
| SCHEMBL11983217 | 0.77 | KDM4E (0.50) | POLBMEN1KMT2APTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2597954-A1 | DEUTERATED N-ETHYL-N-PHENYL-1,2-DIHYDRO-4-HYDROXY-5-CHLORO-1-METHYL-2-OXOQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF | Teva Pharmaceutical Industries Ltd. (IL) | 2013-06-05 | — | — | EP | claimed |
| EP-2590653-A1 | 5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF | Teva Pharmaceutical Industries Ltd. (IL) | 2013-05-15 | — | — | EP | claimed |
| WO-2012006538-A1 | DEUTERATED N-ETHYL-N-PHENYL-1,2-DIHYDRO-4-HYDROXY-5-CHLORO-1-METHYL-2-OXOQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2012-01-12 | — | — | WO | claimed |
| WO-2012006544-A1 | 5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2012-01-12 | — | — | WO | claimed |
| EP-2234485-A1 | STABLE LAQUINIMOD PREPARATIONS | Teva Pharmaceutical Industries Ltd. (IL) | 2010-10-06 | — | — | EP | claimed |
| WO-2009082471-A1 | STABLE LAQUINIMOD PREPARATIONS | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2009-07-02 | — | — | WO | claimed |
| WO-2017019862-A1 | COMBINATION FORMULATION OF LAQUINIMOD AND GLATIRAMER ACETATE WITH AMINO ACIDS | TEVA PHARMACEUTICALS INDUSTRIES LTD. (IL) | 2017-02-02 | — | — | WO | disclosed |
| EP-2597954-A1 | DEUTERATED N-ETHYL-N-PHENYL-1,2-DIHYDRO-4-HYDROXY-5-CHLORO-1-METHYL-2-OXOQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF | Teva Pharmaceutical Industries Ltd. (IL) | 2013-06-05 | — | — | EP | disclosed |
| EP-2590653-A1 | 5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF | Teva Pharmaceutical Industries Ltd. (IL) | 2013-05-15 | — | — | EP | disclosed |
| WO-2012006538-A1 | DEUTERATED N-ETHYL-N-PHENYL-1,2-DIHYDRO-4-HYDROXY-5-CHLORO-1-METHYL-2-OXOQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2012-01-12 | — | — | WO | disclosed |
| WO-2012006544-A1 | 5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2012-01-12 | — | — | WO | disclosed |
| EP-2376456-A2 | HIGHLY PURE LAQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Actavis Group Ptc Ehf (IS) | 2011-10-19 | — | — | EP | disclosed |
| EP-2318371-A2 | NOVEL SOLID STATE FORMS OF LAQUINIMOD AND ITS SODIUM SALT | Actavis Group PTC EHF (IS) | 2011-05-11 | — | — | EP | disclosed |
| EP-2234485-A1 | STABLE LAQUINIMOD PREPARATIONS | Teva Pharmaceutical Industries Ltd. (IL) | 2010-10-06 | — | — | EP | disclosed |
| WO-2010070449-A2 | HIGHLY PURE LAQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ACTAVIS GROUP PTC EHF (IS) | 2010-06-24 | — | — | WO | disclosed |
| WO-2010001257-A2 | NOVEL SOLID STATE FORMS OF LAQUINIMOD AND ITS SODIUM SALT | ACTAVIS GROUP PTC EHF (IS) | 2010-01-07 | — | — | WO | disclosed |
| WO-2009082471-A1 | STABLE LAQUINIMOD PREPARATIONS | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2009-07-02 | — | — | WO | disclosed |
| EP-2035001-A2 | STABLE LAQUINIMOD PREPARATIONS | Teva Pharmaceutical Industries Limited (IL) | 2009-03-18 | — | — | EP | disclosed |
| WO-2007146248-A2 | STABLE LAQUINIMOD PREPARATIONS | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2007-12-21 | — | — | WO | disclosed |